Loading…
GeneDx Holdings Corp. is projected to rise to $109.81 by 2027, a +59% move from its current price of $68.96. WGS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $66.37 | $69.00 | $71.74 | +0.06% |
| Aug 2 | $65.35 | $69.04 | $72.94 | +0.12% |
| Aug 3 | $64.59 | $69.09 | $73.89 | +0.18% |
| Aug 4 | $63.96 | $69.13 | $74.71 | +0.24% |
| Aug 5 | $63.41 | $69.17 | $75.45 | +0.30% |
| Aug 6 | $62.93 | $69.21 | $76.12 | +0.36% |
| Aug 7 | $62.49 | $69.25 | $76.75 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $62.49 | $69.25 | $76.75 | +0.42% |
| Week 2 | $60.14 | $69.55 | $80.43 | +0.85% |
| Week 3 | $58.45 | $69.84 | $83.45 | +1.28% |
| Week 4 | $57.10 | $70.14 | $86.15 | +1.71% |
| Week 5 | $55.97 | $70.43 | $88.64 | +2.14% |
| Week 6 | $54.99 | $70.73 | $90.99 | +2.57% |
| Week 7 | $54.12 | $71.03 | $93.23 | +3.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GeneDx Holdings Corp. is a genomics company that provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp. trades under the symbol WGS. The current price is $68.96 and the market capitalization is $2.05B. It is ranked 1891.
The 30-day technical picture shows a bullish sentiment with RSI14 at 60. The 50-day simple moving average sits at $59.52 and the 200-day simple moving average sits at $91.32. Support is $55.42 and resistance is $71.71. The 30-day price range runs from $53.38 to $89.09.
The year-by-year forecast indicates a rising path from 2026 onward, starting with an average of $68.96 in 2026 and increasing to $109.81 in 2027, $151.61 in 2028, $179.54 in 2029, $198.65 in 2030, $208.19 in 2031, $255.50 in 2032, $315.32 in 2033, $384.60 in 2034, and $477.99 in 2035, with continued growth to $796.53 in 2040 and $1,555.46 in 2050.
A major floor 50.0% below — a decisive break under it would weaken the trend.
The nearest floor, 19.6% below — buyers have tended to step in here.
The nearest ceiling, 4.0% above — a clean break opens room to run.
A major ceiling 18.4% above — clearing it would confirm fresh momentum.
Key WGS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WGS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $62.83 | Buy | $64.44 | Buy |
| MA 10 | $62.59 | Buy | $63.61 | Buy |
| MA 20 | $64.13 | Buy | $63.28 | Buy |
| MA 50 | $59.52 | Buy | $62.08 | Buy |
| MA 100 | $61.16 | Buy | $67.18 | Buy |
| MA 200 | $91.32 | Sell | $77.74 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.55 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 131.19 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | 10.46 | Buy |
| Bollinger %B (20,2) | 0.92 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | -0.87 | Sell |
| Ultimate (7,14,28) | 65.59 | Neutral |
| Momentum (10) | 7.27 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 64.35 | Buy |
| ADX (14) | 10.36 | Neutral |
| ATR (14) | 2.48 | Info |
The 30-day technical picture for GeneDx shows a bullish tilt. RSI14 is 60, with a SMA50 of $59.52 and a SMA200 of $91.32, placing the current price near the shorter-term moving average but below the longer-term gauge. Immediate support sits at $55.42 and resistance at $71.71, with the surrounding 30-day range spanning $53.38 to $89.09.
Overall, the setup suggests room for near-term upside within the established trading band, though volatility remains a consideration given the recent range and the stock’s annualized volatility of 70.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $34.51 | $68.96 | $96.67 | 0% | Neutral | |
| $84.20 | $109.81 | $153.29 | +59% | Bullish | |
| $111.46 | $151.61 | $222.59 | +120% | Bullish | |
| $127.43 | $179.54 | $274.02 | +160% | Bullish | |
| $136.65 | $198.65 | $313.15 | +188% | Bullish | |
| $139.14 | $208.19 | $337.48 | +202% | Bullish | |
| $166.19 | $255.50 | $424.59 | +271% | Bullish | |
| $199.91 | $315.32 | $535.86 | +357% | Bullish | |
| $237.92 | $384.60 | $667.13 | +458% | Bullish | |
| $288.76 | $477.99 | $844.97 | +593% | Bullish | |
| $430.93 | $796.53 | $1,522.95 | +10.6x | Bullish | |
| $699.95 | $1,555.46 | $3,326.36 | +21.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $34.51 | $68.96 | $80.71 | +0.00% |
| August 2026 | $61.88 | $73.27 | $89.27 | +6.25% |
| September 2026 | $60.80 | $72.87 | $90.46 | -0.55% |
| October 2026 | $58.04 | $70.23 | $88.48 | -3.62% |
| November 2026 | $59.29 | $72.32 | $92.19 | +2.97% |
| December 2026 | $61.06 | $75.03 | $96.67 | +3.74% |
Click any year to see its month-by-month WGS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, WGS is projected to trade between $34.51 and $96.67, averaging $68.96 — a potential gain of 0% from today's $68.96. Price action looks broadly range-bound.
GeneDx Holdings Corp.'s 2027 outlook centres on $109.81, within a $84.20 to $153.29 range. That is up +59% on the projected 2026 average. That marks a +59% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, WGS could reach as high as $222.59, with a base case around $151.61 and support toward $111.46 — roughly +120% from $68.96. Momentum favours further upside here.
Expect WGS to range from $127.43 to $274.02 through 2029. The $179.54 average target implies a +160% move from current prices. That is up +18% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The WGS price prediction for 2030 points to an average of $198.65 (low $136.65, high $313.15) — a potential gain of +188% on today's $68.96. Momentum favours further upside here.
In 2031, WGS is projected to trade between $139.14 and $337.48, averaging $208.19 — a potential gain of +202% from today's $68.96. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
GeneDx Holdings Corp.'s 2032 outlook centres on $255.50, within a $166.19 to $424.59 range. That is up +23% on the projected 2031 average. That marks a +271% change versus current levels. Momentum favours further upside here.
By 2033, WGS could reach as high as $535.86, with a base case around $315.32 and support toward $199.91 — roughly +357% from $68.96. Buyers look set to stay in control over this stretch.
Expect WGS to range from $237.92 to $667.13 through 2034. The $384.60 average target implies a +458% move from current prices. That is up +22% on the projected 2033 average. Momentum favours further upside here.
The WGS price prediction for 2035 points to an average of $477.99 (low $288.76, high $844.97) — a potential gain of +593% on today's $68.96. Buyers look set to stay in control over this stretch.
In 2040, WGS is projected to trade between $430.93 and $1,522.95, averaging $796.53 — a potential gain of +10.6x from today's $68.96. That is up +67% on the projected 2035 average. Momentum favours further upside here.
GeneDx Holdings Corp.'s 2050 outlook centres on $1,555.46, within a $699.95 to $3,326.36 range. That is up +95% on the projected 2040 average. That marks a +21.6x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in WGS today (≈ 14.50116 WGS) could be worth
$22,555.9
+$21,555.9 (+2156%) by 2050 · US Dollar
Based on the average projected WGS price of $1,555.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WGSwould be worth at today's price.
$1,000 invested in WGS on Jul 30, 2025 (≈ 9.660902 WGS) would be worth
$666.22
-$333.78 (-33.4%) today · 0.67× · US Dollar
Based on a WGS entry price of $103.51 vs. today's $68.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $63.38 | $1,088.04 | +8.8% |
| 1 month ago | $68.65 | $1,004.52 | +0.5% |
| 3 months ago | $65.38 | $1,054.76 | +5.5% |
| 6 months ago | $96.26 | $716.39 | -28.4% |
| 1 year ago | $103.51 | $666.22 | -33.4% |
| All time (5.0y) ago | $373.89 | $184.44 | -81.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WGS forecast.
Our base-case forecast reaches $140.00 around 2028.
Implied market cap at $140.00: $4.16B
The multi-year forecast paints a bullish trajectory, with the 2030 average at $198.65 and an implied ROI of 188.1, signaling meaningful upside from current levels. The outlook remains bullish through 2031 and beyond, supported by a rising pattern across subsequent years.
By 2040, the average forecast climbs to $796.53 with an ROI of 1055.1, and by 2050 the average forecast reaches $1,555.46 with an ROI of 2155.6. These figures illustrate a sustained, high-growth view over the long term, tempered by the inherent uncertainty of any market projection.
These are estimates based on the provided year-by-year forecast and should be treated as directional indicators rather than guarantees.
Tap a question to reveal the answer.
2030 avg is $198.65 with a min of $136.65 and a max of $313.15; ROI 188.1; sentiment BULLISH.
The forecast shows bullish sentiment starting in 2027 with an avg of $109.81 and rising to $198.65 in 2030 and $1,555.46 in 2050, with ROI reaching 59.2% in 2027 and 2155.6% in 2050. These are estimates, not guarantees.
Yes. The 2040 max forecast is $1,522.95 and the 2050 max forecast is $3,326.36, so surpassing $1,000 is possible by 2040 at the latest according to the numbers provided.
The current price is $68.96 and the market cap is $2.05B.
RSI14 is 60 with a bullish sentiment; SMA50 is $59.52 and SMA200 is $91.32. Support is $55.42 and resistance is $71.71, with a 30-day range of $53.38 to $89.09. Annualized volatility is 70.
GeneDx Holdings Corp. Community Discussion
0Share your GeneDx Holdings Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.